372 related articles for article (PubMed ID: 8454844)
21. MHC-unrestricted lysis of MUC1-expressing cells by human peripheral blood mononuclear cells.
Wright SE; Rewers-Felkins KA; Quinlin IS; Fogler WE; Phillips CA; Townsend M; Robinson W; Philip R
Immunol Invest; 2008; 37(3):215-25. PubMed ID: 18389441
[TBL] [Abstract][Full Text] [Related]
22. Human T cell leukemia/lymphoma virus type I infection of a CD4+ proliferative/cytotoxic T cell clone progresses in at least two distinct phases based on changes in function and phenotype of the infected cells.
Yssel H; de Waal Malefyt R; Duc Dodon MD; Blanchard D; Gazzolo L; de Vries JE; Spits H
J Immunol; 1989 Apr; 142(7):2279-89. PubMed ID: 2466894
[TBL] [Abstract][Full Text] [Related]
23. Major histocompatibility complex class I-restricted activation of cloned T cells by a soluble protein in the absence of accessory cells.
Dick T; Reske-Kunz AB
Proc Natl Acad Sci U S A; 1989 Apr; 86(7):2316-20. PubMed ID: 2784568
[TBL] [Abstract][Full Text] [Related]
24. Functional heterogeneity in allospecific cytotoxic T lymphocyte clones. II. Development of syngeneic cytotoxicity in the absence of specific antigenic stimulation.
Claesson MH; Miller RG
J Immunol; 1985 Feb; 134(2):684-90. PubMed ID: 2578160
[TBL] [Abstract][Full Text] [Related]
25. Induction of class I MHC-restricted, peptide-specific cytolytic T lymphocytes by peptide priming in vivo.
Ishioka GY; Colon S; Miles C; Grey HM; Chesnut RW
J Immunol; 1989 Aug; 143(4):1094-100. PubMed ID: 2787356
[TBL] [Abstract][Full Text] [Related]
26. Analysis of the role of MHC class II presentation in the stimulation of cytotoxic T lymphocytes by antigens targeted into the exogenous antigen-MHC class I presentation pathway.
Rock KL; Clark K
J Immunol; 1996 May; 156(10):3721-6. PubMed ID: 8621907
[TBL] [Abstract][Full Text] [Related]
27. Failure or success in the restoration of virus-specific cytotoxic T lymphocyte response defects by dendritic cells.
Kast WM; Boog CJ; Roep BO; Voordouw AC; Melief CJ
J Immunol; 1988 May; 140(9):3186-93. PubMed ID: 2834454
[TBL] [Abstract][Full Text] [Related]
28. Anti-tumor activity of class II MHC antigen-restricted cloned autoreactive T cells. I. Destruction of B16 melanoma cells mediated by bystander cytolysis in vitro.
Shiohara T; Ruddle NH; Horowitz M; Moellmann GE; Lerner AB
J Immunol; 1987 Mar; 138(6):1971-8. PubMed ID: 3102609
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-2 gene-transduced human leukemic cells induce major histocompatibility complex-restricted and -unrestricted anti-leukemic effectors in mixed lymphocyte-tumor cultures.
Cignetti A; Guarini A; Gillio Tos A; Reato G; Foa R
Cancer Gene Ther; 2000 Feb; 7(2):167-76. PubMed ID: 10770624
[TBL] [Abstract][Full Text] [Related]
30. Peptide-dependent recognition of H-2Kb by alloreactive cytotoxic T lymphocytes.
Heath WR; Hurd ME; Carbone FR; Sherman LA
Nature; 1989 Oct; 341(6244):749-52. PubMed ID: 2477713
[TBL] [Abstract][Full Text] [Related]
31. Induction of cytotoxic lymphocyte responses by antigen-specific helper factors.
Krowka JF; Shiozawa C; Diener E; Paetkau V; Pilarski LM
J Immunol; 1984 Oct; 133(4):2018-24. PubMed ID: 6206146
[TBL] [Abstract][Full Text] [Related]
32. Characterization of tumor-specific cytotoxic effector cells with a novel CD3-/Thy-1+ phenotype.
Sabapathy TK; Cheng Q; Hui KM
Cell Immunol; 1995 Nov; 166(1):141-53. PubMed ID: 7585974
[TBL] [Abstract][Full Text] [Related]
33. Alloantigenic sites on class I major histocompatibility complex antigens: 61-69 region in the first domain of the H-2Kb molecule induces specific antibody and T cell responses.
Singh B; Waters CA; Swanlund D
J Immunol; 1986 Oct; 137(7):2311-8. PubMed ID: 2428867
[TBL] [Abstract][Full Text] [Related]
34. Unrestricted recognition of a nonpeptide antigen by CD8+ cytolytic T lymphocytes.
Sherman LA; Lara AM
J Immunol; 1989 Dec; 143(11):3444-7. PubMed ID: 2479678
[TBL] [Abstract][Full Text] [Related]
35. Monoclonal antibodies against an H-2Kb-specific cytotoxic T cell clone detect several clone-specific molecules.
Hua C; Boyer C; Buferne M; Schmitt-Verhulst AM
J Immunol; 1986 Mar; 136(6):1937-44. PubMed ID: 3485135
[TBL] [Abstract][Full Text] [Related]
36. Studies on the induction and expression of T cell-mediated immunity. XV. Role of non-MHC papain-sensitive target structures and Lyt-2 antigens in allogeneic and xenogeneic lectin-dependent cellular cytotoxicity (LDCC).
Bonavida B; Katz J
J Immunol; 1985 Sep; 135(3):1616-23. PubMed ID: 3874903
[TBL] [Abstract][Full Text] [Related]
37. MHC-restricted cytotoxic response of chicken T cells: expression, augmentation, and clonal characterization.
Maccubbin DL; Schierman LW
J Immunol; 1986 Jan; 136(1):12-6. PubMed ID: 2415611
[TBL] [Abstract][Full Text] [Related]
38. Antigen recognition and allogeneic tumor rejection in CD8+ TCR transgenic/RAG(-/-) mice.
Manning TC; Rund LA; Gruber MM; Fallarino F; Gajewski TF; Kranz DM
J Immunol; 1997 Nov; 159(10):4665-75. PubMed ID: 9366389
[TBL] [Abstract][Full Text] [Related]
39. CD4+ T cell-mediated killing of major histocompatibility complex class II-positive antigen-presenting cells (APC). III. CD4+ cytotoxic T cells induce apoptosis of APC.
Grogg D; Hahn S; Erb P
Eur J Immunol; 1992 Jan; 22(1):267-72. PubMed ID: 1346113
[TBL] [Abstract][Full Text] [Related]
40. Isolation from Trypanosoma cruzi-infected mice of CD8+, MHC-restricted cytotoxic T cells that lyse parasite-infected target cells.
Nickell SP; Stryker GA; Arevalo C
J Immunol; 1993 Feb; 150(4):1446-57. PubMed ID: 8432987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
